局部前列腺素激动剂治疗后眼眶脂肪体积变化
本研究对比23例长期使用前列腺素类似物(PGA)治疗且眼压从未超过21 mmHg的原发性开角型青光眼(POAG)患者与21例年龄匹配对照,用高分辨率磁共振测量眼眶脂肪体积(OFV)。结果显示POAG组滑车至眶尖区域OFV显著低于对照组,但前部眼眶OFV相似;POAG组骨性眼眶宽度和截面积更小,提示OFV降低可能与水平方向较窄的骨性眼眶相关。
要点
- POAG患者长期使用PGA后滑车至眶尖区域OFV显著低于对照。
- 前部眼眶(GONJ至滑车)OFV两组相似,无显著差异。
- POAG组骨性眼眶宽度和截面积显著小于对照。
核心结论
- 长期使用PGA的POAG患者整体眼眶脂肪体积低于年龄匹配对照,但前部眼眶脂肪体积相似。
- POAG患者整体OFV较低可能与水平方向较窄的骨性眼眶相关,后者可能是非高眼压POAG的危险因素。
研究设计与样本
- 研究纳入23例长期使用PGA治疗且眼压从未超过21 mmHg的POAG患者,与21例年龄匹配对照比较。
- 使用高分辨率磁共振成像测量眼眶体积、非脂肪眼眶组织体积和眼眶脂肪体积。
主要发现
- POAG组PGA治疗时间为39 ± 19个月(SD),所有患者在研究前4个月内均在接受治疗。
- 滑车至眶尖区域OFV在POAG组为9.8 ± 1.9 mL,显著低于对照组的11.1 ± 1.3 mL(P = 0.019)。
- 眼球-视神经连接处(GONJ)至滑车区域OFV两组相似。
- POAG组骨性眼眶宽度和截面积显著小于对照(P < 0.0001)。
- GONJ后方平均眼眶截面积在POAG组小68.2 mm2,整个眼眶宽度平均小1.5 mm。
临床怎么用
- 对长期使用PGA的POAG患者,应关注眼眶脂肪体积变化及眼眶骨性结构特征。
- 水平方向较窄的骨性眼眶可能是非高眼压POAG的危险因素,提示临床评估时需综合考虑眼眶解剖。
局限性
- 样本量较小(POAG组23例,对照组21例),结论需更大样本验证。
- 研究为横断面比较,无法确定PGA治疗与眼眶脂肪体积降低的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Topical prostaglandin analogs (PGAs) are common treatment for primary open-angle glaucoma (POAG) but reportedly may cause adnexal fat atrophy. We asked if patients with POAG treated with PGAs have abnormalities in orbital fat volume (OFV). METHODS: We studied 23 subjects with POAG who had never experienced intraocular pressure (IOP) exceeding 21 mm Hg and were treated long term with PGAs, in comparison with 21 age-matched controls. Orbital volume, non-fat orbital tissue volume, and OFV were measured using high-resolution magnetic resonance imaging. RESULTS: Subjects with POAG had been treated with PGAs for 39 ± 19 months (SD) and were all treated within the 4 months preceding study. In the region from trochlea to orbital apex, OFV in POAG was significantly less at 9.8 ± 1.9 mL than in the control subjects at 11.1 ± 1.3 mL (P = 0.019). However, between the globe-optic nerve junction (GONJ) and trochlea, OFV was similar in both groups. Width and cross sectional area of the bony orbit were significantly smaller in POAG than in controls (P < 0.0001). Posterior to the GONJ, the average orbital cross-sectional area was 68.2 mm2 smaller, and the orbital width averaged 1.5 mm smaller throughout the orbit, in patients with POAG than in controls. CONCLUSIONS: Patients with POAG who have been treated with PGAs have lower overall OFV than controls, but OFV in the anterior orbit is similar in both groups. Lower overall OFV in POAG may be a primary association of this disorder with a horizontally narrower bony orbit, which may be a risk factor for POAG at nonelevated IOPs.
引用
- Chen JY, Le A, Caprioli J, et al. Orbital Fat Volume After Treatment with Topical Prostaglandin Agonists. Invest Ophthalmol Vis Sci. 2020. PMID: 32455434. doi:10.1167/iovs.61.5.46
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。